Clinical Trials Logo

Neurocysticercosis clinical trials

View clinical trials related to Neurocysticercosis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06376396 Not yet recruiting - Neurocysticercosis Clinical Trials

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

NeuroSolve
Start date: June 2024
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare the combination albendazole and praziquantel versus albendazole alone in patients affected by neurocysticercosis.

NCT ID: NCT04706819 Not yet recruiting - Neurocysticercosis Clinical Trials

Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study

Start date: January 15, 2021
Phase:
Study type: Observational [Patient Registry]

Neurocysticercosis(NCC) is the commonest parasitic infection of the central nervous system. It is the commonest cause of focal seizures in India. It can also present with headaches, movement disorders, stroke, cognitive decline and multitude of complications depending on its location. Parenchymal NCC is more common than extraparenchymal NCC. There is considerable variation in the treatment practices including administration of anti-helminthic agents and corticosteroids. Extra-parenchymal NCC is rare and can occur in the subarachnoid space or intraventricularly. Extra-parenchymal NCC is managed surgically in several instances. There is scant literature on the long term follow up of this condition. This registry will enable collection of data on the clinical, laboratory and imaging features, treatment trends and long term outcomes of both parenchymal and extra-parenchymal neurocysticercosis.